Increasing Access to Multiple Micronutrient Supplementation - A Pilot Intervention at up to 15 Clinics in Botswana
Launched by UNIVERSITY OF PENNSYLVANIA · Jan 25, 2023
Trial Information
Current as of August 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women attending interventional antenatal clinics during the 6-month study
- Exclusion Criteria:
- • None
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Block 8, Gaborone, Botswana
Kopong, Molepolole, Botswana
Gaborone, , Botswana
Gaborone, , Botswana
Gaborone, , Botswana
Gaborone, , Botswana
Gaborone, , Botswana
Molepolole, , Botswana
Molepolole, , Botswana
Molepolole, , Botswana
Molepolole, , Botswana
Palapye, , Botswana
Palapye, , Botswana
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials